REYON Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	4,290	6,667	10,209	24,107	16,049	66,741
Short-Term Investments	-	-	-	-	20,000	30,380
Trading Asset Securities	60.81	115.03	6.05	134.02	19.83	327.64
Cash & Short-Term Investments	4,351	6,782	10,215	24,241	36,069	97,448
Cash Growth	-50.64%	-33.61%	-57.86%	-32.79%	-62.99%	114.32%
Accounts Receivable	35,463	34,381	36,720	39,927	41,810	40,465
Other Receivables	403.1	299.59	442.44	50.98	238.02	384.38
Receivables	35,866	34,680	37,162	39,978	42,048	40,850
Inventory	36,466	37,930	41,991	35,176	30,109	26,432
Prepaid Expenses	49.09	77.75	28.03	229.57	28.53	32.51
Other Current Assets	54.24	195.14	47.67	188.61	751.89	41.89
Total Current Assets	76,786	79,665	89,443	99,813	109,006	164,804
Property, Plant & Equipment	354,780	361,230	384,397	368,342	340,568	281,156
Long-Term Investments	17,936	18,931	16,011	21,216	26,211	24,557
Other Intangible Assets	1,073	1,480	1,803	1,392	1,404	1,427
Long-Term Deferred Tax Assets	-	-	4,408	5,075	4,104	2,004
Long-Term Deferred Charges	2,800	2,800	2,800	2,800	2,800	2,800
Other Long-Term Assets	1,008	993.89	1,131	1,137	598.41	1,230
Total Assets	454,383	465,100	499,994	499,776	484,692	477,978
Accounts Payable	6,122	8,659	10,028	8,186	4,793	4,731
Accrued Expenses	3,348	3,269	3,513	3,776	3,646	2,253
Short-Term Debt	106,877	101,464	81,201	94,656	22,500	22,500
Current Portion of Long-Term Debt	16,000	14,000	8,000	6,000	-	-
Current Portion of Leases	705.03	951.94	1,458	1,610	2,254	1,911
Current Income Taxes Payable	-	-	-	852.4	733.48	426.48
Other Current Liabilities	14,779	14,987	31,336	10,522	14,025	15,682
Total Current Liabilities	147,831	143,331	135,537	125,602	47,951	47,503
Long-Term Debt	95,000	99,000	113,000	121,000	184,218	182,425
Long-Term Leases	590.78	698.76	392.9	1,788	1,231	478.19
Long-Term Deferred Tax Liabilities	237.27	656.46	65.84	12.95	-	7.09
Other Long-Term Liabilities	1,141	1,141	1,057	2,748	3,526	2,328
Total Liabilities	244,799	244,827	250,053	251,151	236,926	232,741
Common Stock	9,293	9,293	9,293	9,293	8,999	8,999
Additional Paid-In Capital	38,955	38,955	38,955	38,955	39,003	39,003
Retained Earnings	167,027	177,764	207,397	205,997	205,151	202,281
Treasury Stock	-5,079	-5,079	-5,078	-5,079	-5,079	-5,079
Comprehensive Income & Other	-612.44	-660.39	-626	-541.75	-559.4	-217.03
Total Common Equity	209,584	220,273	249,941	248,625	247,515	244,987
Shareholders' Equity	209,584	220,273	249,941	248,625	247,765	245,237
Total Liabilities & Equity	454,383	465,100	499,994	499,776	484,692	477,978
Total Debt	219,173	216,115	204,053	225,054	210,203	207,314
Net Cash (Debt)	-214,822	-209,333	-193,838	-200,813	-174,134	-109,866
Net Cash Per Share	-11657.65	-11413.42	-10552.84	-10948.85	-9538.14	-6200.33
Filing Date Shares Outstanding	18.35	18.34	18.34	18.34	17.75	17.75
Total Common Shares Outstanding	18.35	18.34	18.34	18.34	18.25	17.75
Working Capital	-71,044	-63,666	-46,093	-25,789	61,055	117,301
Book Value Per Share	11419.12	12009.87	13627.46	13555.68	13560.43	13799.95
Tangible Book Value	208,511	218,793	248,138	247,233	246,111	243,561
Tangible Book Value Per Share	11360.66	11929.17	13529.15	13479.79	13483.51	13719.59
Land	12,362	12,362	12,362	12,362	12,362	12,362
Buildings	209,537	209,537	209,537	12,712	12,712	12,712
Machinery	169,670	169,264	166,017	43,939	42,519	39,530
Construction In Progress	50,741	49,554	45,487	342,022	314,018	256,737